These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4740371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of nandrolone phenpropionate on myelopoiesis.
    Kahn SB, Conroy JF, Brodsky I.
    J Med; 1974; 5(6):303-9. PubMed ID: 4528544
    [No Abstract] [Full Text] [Related]

  • 3. [High doses of anabolic steroids in collateral therapy of malignant neoplasms. Results with 19-norandrostenolone undecylate].
    Algeri R, Camarri E, Giomi S.
    Clin Ter; 1978 Jun 15; 85(5):505-15. PubMed ID: 679635
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential roles of androgens and the anabolic steroids in the treatment of cancer - a review.
    Rigberg SV, Brodsky I.
    J Med; 1975 Jun 15; 6(3-4):271-90. PubMed ID: 1104734
    [Abstract] [Full Text] [Related]

  • 7. [Catamnestic results following therapy of heart patients with anabolic steroids].
    Fiegel G, Bargheer R.
    Med Klin; 1966 Nov 25; 61(47):1870-2. PubMed ID: 5989967
    [No Abstract] [Full Text] [Related]

  • 8. [Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].
    Nowakowski H.
    Strahlentherapie; 1974 Apr 25; 147(4):388-400. PubMed ID: 4409449
    [No Abstract] [Full Text] [Related]

  • 9. Androgens and human blood volume changes. Comparison in normal and various anemic states.
    Besa EC, Gorshein D, Gardner FH.
    Arch Intern Med; 1974 Mar 25; 133(3):418-25. PubMed ID: 4521323
    [No Abstract] [Full Text] [Related]

  • 10. [Long-term treatment of medullary insufficiency with androgens].
    Najean Y, Dresh C, Laprevotte I.
    Minerva Med; 1971 Jun 27; 62(51):2588-97. PubMed ID: 5566872
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer.
    Spiers AS, DeVita SF, Allar MJ, Richards S, Sedransk N.
    J Med; 1981 Jun 27; 12(6):433-45. PubMed ID: 7033426
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [6-methylprednisolone acetate (6-MPA): an alternative treatment in oncology].
    Azzoni P, Dal Negro R, Turco P.
    Minerva Med; 1978 Sep 15; 69(42):2861-7. PubMed ID: 278910
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy. Changing concepts in therapy.
    Wright JC.
    Minn Med; 1970 Apr 15; 53(4):373-7. PubMed ID: 5467605
    [No Abstract] [Full Text] [Related]

  • 18. Cytotoxic agents in the treatment of malignant disease.
    Br Med J; 1968 Nov 16; 4(5628):438-9. PubMed ID: 4972069
    [No Abstract] [Full Text] [Related]

  • 19. [Long-term survival after treatment of breast cancer thoracic metastases through the association, right from the beginning, of hormonotherapy and non hormonal antineoplastic chemotherapy (author's transl)].
    Mannes P, Derriks R, Moens R.
    Acta Tuberc Pneumol Belg; 1971 Nov 16; 62(5):473-77. PubMed ID: 5172849
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.